In the event of an inadvertent temperature excursion the following data may be used:
Eptifibatide solution for infusion 0.75 mg/mL and eptifibatide solution for injection 2 mg/mL are stable when stored for 1 month at 25°C/60% relative humidity.
Please also refer to the manufacturer’s product literature for recommended storage information at https://www.medicines.org.uk.
Contact GSK in cases where the product has been exposed to temperature deviation other than described above. Refer to the current BNF for company contact details.